comparemela.com

Latest Breaking News On - Cory freedland - Page 1 : comparemela.com

OrsoBio raises $60m to advance treatment for obesity

OrsoBio has raised $60m in Series A financing to advance its metabolic portfolio for the treatment of obesity and associated disorders.

Edd flemingMani subramanianEli lillyCory freedlandMatthew youngSrini akkarajuEnavate sciencesLongitude capitalSamsara biocapital

OrsoBio Raises $60M Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Cory freedlandMani subramanianMatthew youngEli lillyEdd flemingSrini akkarajuEnavate sciencesMenlo parkLongitude capitalSamsara biocapitalOrsobio board

Alpha-9 Theranostics Raises $75M in Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesUnited kingdomBritish columbiaKuo shyan linMelissa mccrackenDavid perrinMatthew youngPatrick heronDarcy mootzCory freedlandUniversity of british columbiaSanofi companyPartner at frazier life sciencesFrazier life sciencesNextech investSamsara biocapital

Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer

Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

British columbiaUnited statesUnited kingdomMatthew youngPatrick heronDarcy mootzCory freedlandPrnewswire alphaKuo shyan linDavid perrinMelissa mccrackenDavid hirschTheranostics incUniversity of british columbiaSanofi companyPartner at frazier life sciences

Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer

Company is developing bespoke radiopharmaceuticals with capital efficient and rapid approachProceeds to support progression of five candidates int.

British columbiaUnited statesUnited kingdomMatthew youngPatrick heronDarcy mootzCory freedlandPrnewswire alphaKuo shyan linDavid perrinMelissa mccrackenDavid hirschTheranostics incUniversity of british columbiaSanofi companyPartner at frazier life sciences

vimarsana © 2020. All Rights Reserved.